- Research works
- 49 ▼ 61% vs 2013–17
- Citations
- 1.2k 24.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: EVER Neuro Pharma (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 27.7×. Every wedge is a field page.
Who are the top researchers at EVER Neuro Pharma (Austria)?
Ranked on the composite score, Herbert Moessler lead among researchers whose main affiliation is EVER Neuro Pharma (Austria).
- 1 Herbert Moessler Austria · #470,990 worldwide 53 citations · 22 works
Which keywords describe research at EVER Neuro Pharma (Austria)?
By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Alzheimer's Disease, Neuroprotection, Ischemic Stroke, Retinal Ganglion Cells, Mitochondrial Dysfunction, Cerebrolysin and Citicoline.
- Sleep
- Consolidation
- Carnosine
- Cerebral Blood Flow
- Aging
- Neuroinflammation
- Lipoic Acid
- Diabetes
- Rhodiola Rosea
- Acetylcholinesterase
- Inflammation
- White Matter Lesions
- Cerebral Hypoperfusion
- Neuroprotective Effects
- Citicoline
- Mitochondrial Dysfunction
- Ischemic Stroke
- Alzheimer's Disease
- Oxidative Stress
- Neuroprotection
- Retinal Ganglion Cells
- Cerebrolysin
- Neurodegenerative Diseases
- Memory Impairment
- Vascular Cognitive Impairment
- Antioxidant
- Antioxidant Activity
- Cholinesterase Inhibitors
- Salidroside
- Exercise Performance
- Pyruvate Dehydrogenase Complex
- Metabolism
- Cancer
- Neurodegeneration
- ß-Alanine Supplementation
- Memory
- Health Effects
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 37 words, with their numbers
- Oxidative Stress23▲ 26×12 topics
- Alzheimer's Disease16▲ 120×5 topics
- Neuroprotection15▲ 84×6 topics
- Ischemic Stroke13▲ 203×3 topics
- Retinal Ganglion Cells13▲ 203×2 topics
- Mitochondrial Dysfunction13▲ 73×3 topics
- Cerebrolysin13▲ 997×1 topic
- Citicoline13▲ 997×1 topic
- Neurodegenerative Diseases9▲ 83×2 topics
- Neuroprotective Effects8▲ 135×3 topics
- Memory Impairment6▲ 367×2 topics
- Cerebral Hypoperfusion6▲ 411×1 topic
- Vascular Cognitive Impairment6▲ 411×1 topic
- White Matter Lesions6▲ 334×2 topics
- Antioxidant4▲ 11×7 topics
- Inflammation4▲ 3.4×13 topics
- Antioxidant Activity4▲ 13×4 topics
- Acetylcholinesterase3▲ 219×1 topic
- Cholinesterase Inhibitors3▲ 219×1 topic
- Rhodiola Rosea3▲ 637×1 topic
- Salidroside3▲ 637×1 topic
- Diabetes2▲ 7.6×3 topics
- Exercise Performance2▲ 58×2 topics
- Lipoic Acid2▲ 263×1 topic
- Pyruvate Dehydrogenase Complex2▲ 263×1 topic
- Neuroinflammation2▲ 12×4 topics
- Metabolism2▲ 4.8×3 topics
- Aging1▲ 5.4×3 topics
- Cancer1▲ 2.0×8 topics
- Cerebral Blood Flow1▲ 33×2 topics
- Neurodegeneration1▲ 8.4×6 topics
- Carnosine1▲ 67×1 topic
- ß-Alanine Supplementation1▲ 67×1 topic
- Consolidation1▲ 53×1 topic
- Memory1▲ 8.9×2 topics
- Sleep1▲ 53×1 topic
- Health Effects1▲ 3.4×2 topics
Which research topics does EVER Neuro Pharma (Austria) publish most on?
By volume in 2022–2025: Neurological Disorders and Treatments, Neurological Disease Mechanisms and Treatments, Medicinal Plants and Bioactive Compounds and Statistical Methods in Clinical Trials.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neurological Disorders and Treatments Neurology 1 works
- 2 Neurological Disease Mechanisms and Treatments Neurology 0 works
- 3 Medicinal Plants and Bioactive Compounds Molecular Biology 0 works
- 4 Statistical Methods in Clinical Trials Statistics and Probability 0 works
- 5 Clinical Laboratory Practices and Quality Control Physiology 0 works
- 6 Biosimilars and Bioanalytical Methods Immunology 0 works
- 7 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
- 8 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
- 9 Trace Elements in Health Nutrition and Dietetics 0 works
- 10 Alzheimer's disease research and treatments Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has EVER Neuro Pharma (Austria)'s research output changed?
Output in 2018–2022 was 61% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.